(-0.02%) 5 330.75 points
(0.02%) 39 952 points
(-0.15%) 18 735 points
(-2.08%) $78.14
(-2.73%) $2.68
(-0.27%) $2 431.90
(-1.30%) $32.01
(-0.49%) $1 058.50
(0.03%) $0.921
(-0.28%) $10.67
(-0.04%) $0.787
(-0.17%) $90.52
Live Chart Being Loaded With Signals
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics...
Stats | |
---|---|
今日成交量 | 267 471 |
平均成交量 | 891 846 |
市值 | 47.78M |
EPS | $0 ( 2024-05-10 ) |
下一个收益日期 | ( $-0.0800 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.790 |
ATR14 | $0.00200 (0.52%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | General Resonance Llc | Sell | 13 000 | Common Stock |
2024-05-01 | General Resonance Llc | Sell | 13 000 | Common Stock |
2024-04-24 | General Resonance Llc | Sell | 10 000 | Common Stock |
2024-04-09 | General Resonance Llc | Sell | 7 500 | Common Stock |
2024-04-09 | General Resonance Llc | Sell | 7 500 | Common Stock |
INSIDER POWER |
---|
98.96 |
Last 99 transactions |
Buy: 46 123 962 | Sell: 192 230 |
音量 相关性
Clene Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Clene Inc. 相关性 - 货币/商品
Clene Inc. 财务报表
Annual | 2023 |
营收: | $654 000 |
毛利润: | $-1.17M (-179.20 %) |
EPS: | $-0.470 |
FY | 2023 |
营收: | $654 000 |
毛利润: | $-1.17M (-179.20 %) |
EPS: | $-0.470 |
FY | 2022 |
营收: | $473 000 |
毛利润: | $447 000 (94.50 %) |
EPS: | $-0.230 |
FY | 2021 |
营收: | $723 000 |
毛利润: | $434 000 (60.03 %) |
EPS: | $-0.160 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Clene Inc.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。